BRIEF-Swedish Orphan Biovitrum says EMA validates Alprolix marketing authorisation ap

[ahlam1399]

BRIEF-Swedish Orphan Biovitrum says EMA validates Alprolix marketing authorisation ap

BRIEF-Swedish Orphan Biovitrum says EMA validates Alprolix marketing authorisation application
* The European Medicines Agency (EMA) has accepted the companies' marketing authorisation Application (MAA) of Alprolix (rFIXFc), a recombinant factor IX Fc fusion protein product candidate for the treatment of haemophilia B.

??????? ??????: BRIEF-Swedish Orphan Biovitrum says EMA validates Alprolix marketing authorisation ap || ??????: ahlam1399 || ??????: اسم منتداك

https://hameed.nwar.uk/vb

كلمات البحث

العاب ، برامج ، سيارات ، هاكات ، استايلات